Public Health Agency of Canada

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. 

Public Health Agency of Canada (PHAC)’s landing page for multiple public health surveillance programs.

This is the third report of the Public Health Agency of Canada's (PHAC) Injury in Review series, providing important national surveillance statistics on the causes of traumatic brain injuries (TBI) across the life course, including sports, seniors' falls, assaults, consumer products, and more.

This quarterly financial report has been prepared by management as required by section 65.1 of the Financial Administration Act, in the form and manner prescribed by the Directive on Accounting Standards, GC 4400 Departmental Quarterly Financial Report. This quarterly financial report should be...

The HBSC is a World Health Organization, on-going, cross-national research study of youth aged 11 to 15 years old that collects data every 4 years. The study aims to gain insight into young people's: well-being; health behaviours; and social contexts.

This statement contains NACI’s independent advice and recommendations, which are based upon the best current available scientific knowledge. This document is being disseminated for information purposes. People administering the vaccine should also be aware of the contents of the relevant product...

The Future-Oriented Statement of Operations has been prepared on the basis of government priorities and the Public Health Agency of Canada’s (the Agency) plans as described in the Departmental Plan. The information in the forecast results for fiscal year 2019-20 is based on actual results as at...

The National Advisory Committee on Immunization (NACI) is an External Advisory Body that provides the Public Health Agency of Canada (PHAC) with independent, ongoing and timely medical, scientific, and public health advice in response to questions from PHAC relating to immunization. This...

With new, more transmissible variants of the COVID-19 virus in countries around the world, the Government of Canada continues to take a data-driven and precautionary approach to its border measures for travellers entering Canada. The Government of Canada's phased approach to easing border...

The Public Health Agency of Canada (PHAC) released new modelling projections of the number of opioid-related deaths that may occur over the course of the coming months. The results of the model suggest that, under some scenarios, the number of opioid-related deaths may remain high or may even...

This report provides an update on the epidemiology of three nationally notifiable STIs in Canada: chlamydia, gonorrhea and infectious syphilis (including congenital syphilis) using data up to 2018, by province/territory, age group and sex. In addition, updated information related to syphilis...

This is the backgrounder for the mental health and distress centres. Supporting the mental health and well-being of Canadians, particularly during the COVID-19 pandemic, is a priority for the Government of Canada. A $50 million investment to increase the capacity of distress centres across the...

This is the backgrounder for the new Projects Funded Under the Immunization Partnership Fund.

The objective of the Interim National Vaccine Storage, Handling and Transportation Guidelines for Ultra-Low Temperature and Frozen Temperature COVID-19 Vaccines – 2021 is to supplement and update the guidance for storage, handling and transportation of ultra-low temperature and frozen temperature...

The Office of Audit and Evaluation (OAE) Departmental Evaluation Plan for PHAC describes the Program Evaluation Division's scheduled work for the five-year period from 2021-22 to 2025-26. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016), which requires that...

In Canada, facilities where Risk Group 2, 3, and 4 human pathogens or toxins are handled and stored are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

"In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease...